The health economics of blood use in cerebrovascular aneurysm surgery: The experience of a UK centre

European Journal of Anaesthesiology

Volumn 22, Issue 12, 2005, Pages 925-928

  De Gray, L C ^a   Matta, B F ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; Economics, hospital; Intracranial aneurysm; Surgical procedures, operative, intracranial

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE TRANSMISSION; ECONOMIC ASPECT; FEMALE; HEALTH ECONOMICS; HUMAN; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE;

BLOOD GROUPING AND CROSSMATCHING; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COST SAVINGS; HEMATOCRIT; HEMOGLOBINS; HOSPITAL COSTS; HUMANS; INTRACRANIAL ANEURYSM; SUBARACHNOID HEMORRHAGE;

EID: 28444490739     PISSN: 02650215     EISSN: 02650215     Source Type: Journal    
DOI: 10.1017/S0265021505001572     Document Type: Article

References (17)

1. Osawa M, Hongo K, Tanaka Y, Nakamura Y, Kitazawa K, Kobayashi S. Results of direct surgery for aneurismal subarachnoid haemorrhage: outcome of 2055 patients who underwent direct aneurysm surgery and profile of ruptured intracranial aneurysms. Acta Neurochir (Wien) 2001; 143: 655-663; discussion 663-664.
2. Bendo AA. Intracranial vascular surgery. Anesth Clin North Am 2002; 20: 377-388.
3. Le Roux PD, Elliott JP, Winn HR. Blood transfusion during aneurysm surgery. Neurosurgery 2001; 49: 1068-1075.
4. Couture DE, Ellegala DB, Dumont AS, Mintz PD, Kassell NF. Blood use in cerebrovascular neurosurgery. Stroke 2002; 33: 994-997.
5. Kudo T, Suzuki S, Iwabuchi T. Importance of monitoring circulating blood volume in patients with cerebral vasospasm after subarachnoid haemorrhage. Neurosurgery 1981; 9: 514-520.
6. Cogliano J, Kisner D. Bloodless medicine and surgery in the OR and beyond. AORN J 2002; 76: 830-837, 841.
7. Guest JF, Munro V, Cookson RF. The annual cost of blood transfusion in the United Kingdom. Clin Lab Haematol 1998; 20: 111-118.
8. Carter TH. Biotechnology, economics and the business of blood. Biotechnology 1991; 19: 3-30.
9. Llewelyn CA, Hewitt PE, Knight RS et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421.
10. Turner ML. vCJD screening and its implications for transfusion-strategies for the future? Blood Coagul Fibrinol 2003; 14(Suppl 1): S65-S68.
11. Boixiere A, Hergon E, Moutel G, Rouger P, Herve C. Legal obligation to inform the patient on the theoretical risk of CJD transmission by blood transfusion. Clin Biol 2004; 11: 101-105.
12. Glazier DB, Ciocca RG, Gosin JS, Murphy DP, Graham AM. Elective aortic surgery with minimal banked blood. Am Surg 1998; 64: 171-174.
13. Goodhough LT, Monk TG, Sicard G et al. Intra-operative salvage in patients undergoing elective abdominal aortic aneurysm repair: an analysis of cost and benefit. J Vasc Surg 1996; 24: 213-218.
14. Wallace EL. Costing blood products and services. Transfusion 1991; 31: 318-323.
15. van Klei WA, Moons KG, Rheineck-Leyssius AT et al. Validation of a clinical prediction rule to reduce preoperative type and screen procedures. Br J Anaesth 2002; 89: 221-225.
16. Suess S, Suess O, Brock M. Neurosurgical procedures in Jehovah's witnesses: an increased risk? Neurosurgery 2001; 49: 266-272; discussion 272-273.
17. Levenson D. Stop overstocking blood for neurosurgery. Rep Med Guidelines Outcomes Res 2002; 13: 5-7.